Institutional investors purchased a net $366.0 thousand shares of MDCO during the quarter ended December 2014 and now own 105.22% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
ARDEN ASSET MANAGEMENT LLC Bought 40.1 Thousand shares of Medicines Co
SOUND POINT CAPITAL MANAGEMENT L... Bought 28.9 Thousand shares of Medicines Co
LIFESCI INDEX PARTNERS LLC Bought 4.4 Thousand shares of Medicines Co